EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access

Metastatic risk factors in pheochromocytoma/paraganglioma

D V Rebrova, O I Loginova, S L Vorobyev, N V Vorokhobina, E S Kozorezova, F A Indeykin, T V Savelyeva, I V Sleptsov, R A Chernikov, E A Fedorov, A A Semenov, I K Chinchuk and 4 more

Problems of Endocrinology · 2023

DOI: 10.14341/probl13331 ↗

At a glance

Übersichtsarbeit in Problems of Endocrinology, 2023. Written by D V Rebrova and 15 co-authors. Institution: Saint Petersburg State University, Saint Petersburg State University Hospital. Major MEDLINE topics: Pheochromocytoma, Adrenal Gland Neoplasms, Paraganglioma. Cited 1 times so far (Crossref); 50 references. The full text is freely available in PubMed Central.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Currently, all pheochromocytoma/paraganglioma (PPGLs) are considered malignant due to metastatic potential. Consequently, PPGLs are divided into «metastatic» and «non-metastatic». Metastatic PPGLs can be with synchronous metastasis (metastases appear simultaneously with the identified primary tumor) or metachronous (metastases develop after removal of the primary tumor). The term metastatic PPGLs is not used in the presence of tumor invasion into surrounding organs and tissues, without the presence of distant metastases of lymphogenic or hematogenic origin. It is generally believed that about 10% of pheochromocytomas and about 40% of sympathetic paragangliomas have metastatic potential. On average, the prevalence of PPGLs with the presence of metastases is 15–20%. Risk factors for metastatic PPGLs are widely discussed in the literature, the most significant of which are groups of clinical, morphological and genetic characteristics. The review presents a discussion of such risk factors for metastatic PPGLs as age, localization and type of hormonal secretion of the tumor, the size and growth pattern of the adrenal lesion, the presence of necrosis and invasion into the vessels, the tumor capsule surrounding adipose tissue, high cellular and mitotic activity, Ki-67 index, expression of chromogranin B and S100 protein, the presence of genetic mutations of three main clusters (pseudohypoxia, kinase signaling and Wnt signaling). Over the past two decades, a number of authors have proposed various predictor factors and scales for assessing a probability of metastatic PPGLs. The review contains detailed description and comparison of sensitivity and specificity of such predictor scales as PASS, GAPP, M-GAPP, ASES and COPPS.

Subjects

MeSH terms (MEDLINE)

PheochromocytomaAdrenal Gland NeoplasmsParagangliomaHumansRisk FactorsNeoplasm Metastasis

Authors and institutions

  • Saint Petersburg State University, Saint Petersburg State University Hospital.
  • National Clinical Center of Morphological Diagnostic.
  • North-Western State Medical University n.a. I.I. Mechnikov.

Cite

APA

Rebrova, D. V., Loginova, O. I., Vorobyev, S. L., Vorokhobina, N. V., Kozorezova, E. S., Indeykin, F. A., Savelyeva, T. V., Sleptsov, I. V., Chernikov, R. A., Fedorov, E. A., Semenov, A. A., Chinchuk, I. K., Shikhmagomedov, S. S., Alekseev, M. A., Krasnov, L. M., & Rusakov, V. F. (2023). Metastatic risk factors in pheochromocytoma/paraganglioma. Problems of Endocrinology. https://doi.org/10.14341/probl13331

Vancouver

Rebrova DV, Loginova OI, Vorobyev SL, Vorokhobina NV, Kozorezova ES, Indeykin FA, et al. Metastatic risk factors in pheochromocytoma/paraganglioma. Problems of Endocrinology. 2023. doi:10.14341/probl13331

BibTeX
@article{Rebrova2023,
  author = {Rebrova, D V and Loginova, O I and Vorobyev, S L and Vorokhobina, N V and Kozorezova, E S and Indeykin, F A and Savelyeva, T V and Sleptsov, I V and Chernikov, R A and Fedorov, E A and Semenov, A A and Chinchuk, I K and Shikhmagomedov, Sh Sh and Alekseev, M A and Krasnov, L M and Rusakov, V F},
  title = {Metastatic risk factors in pheochromocytoma/paraganglioma},
  journal = {Problems of Endocrinology},
  year = {2023},
  doi = {10.14341/probl13331}
}
Start for free →